Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Core Laboratories Inc. /DE/ | SVP & CFO | Common Stock | 95.7K | $1.66M | $17.31 | Dec 31, 2024 | Direct |
CORE LABORATORIES N V | SVP & CFO | Performance Shares | 52.7K | Feb 16, 2023 | Direct | ||
Core Laboratories Inc. /DE/ | SVP & CFO | Performance Shares | 0 | Dec 31, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLB | Core Laboratories Inc. /DE/ | Dec 31, 2024 | 3 | -$255K | 4 | Jan 3, 2025 | SVP & CFO |
CLB | Core Laboratories Inc. /DE/ | Feb 15, 2024 | 1 | $0 | 4 | Feb 15, 2024 | SVP & CFO |
CLB | Core Laboratories Inc. /DE/ | Dec 31, 2023 | 1 | -$251K | 4/A | Jan 8, 2024 | SVP & CFO |
CLB | Core Laboratories Inc. /DE/ | Dec 31, 2023 | 3 | -$245K | 4 | Jan 3, 2024 | SVP & CFO |
CLB | CORE LABORATORIES N V | Feb 16, 2023 | 1 | $0 | 4 | Feb 21, 2023 | SVP & CFO |
CLB | CORE LABORATORIES N V | Dec 31, 2022 | 3 | -$253K | 4 | Jan 4, 2023 | SVP & CFO |
CLB | CORE LABORATORIES N V | Feb 17, 2022 | 1 | $0 | 4 | Feb 17, 2022 | SVP & CFO |
CLB | CORE LABORATORIES N V | Dec 31, 2021 | 3 | -$207K | 4 | Jan 4, 2022 | SVP & CFO |